ABVX
AbivaxCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
Current thesis
The company-confirmed June 1 ABTECT release supports the efficacy side of the bull case: both tested doses met the primary and key secondary endpoints and no new safety signals were reported in the company's release. If the external malignancy concern is not validated as a material regulatory issue, the stock could re-anchor toward the roughly $151 median target shown in the packet.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.0.
What can break
ABVX remains highly concentrated in obefazimod, so any safety, regulatory, or commercialization setback could sharply compress valuation.
Momentum
93
Value
41
Sentiment
34
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $150.00 · Bull $185.00 · Bear $35.00
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $159.39
Why
Momentum93 · Δ7d -3.0
Value41 · Δ7d +0.1
Sentiment34 · Δ7d +0.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
93
26% active weight
Current posture
7d trendSoftening
Δ7d
-3.0
Δ21d
+83.7
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.0
Sentiment
34
34% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
-35.9
Why this grade
Composite grade C. Momentum 93.1 / Value 41.1 / Sentiment 34.4
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$11.99B
Beta
1.48
Shares Out
87.25M
P/E (TTM) · Derived
-25.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-48.73
Rev YoY
-
EPS YoY
-17.4%
Gross Margin
-
Op Margin
-
Net Debt
-$585.22M
Current Ratio
8.25
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology